Literature DB >> 17581781

Melatonin excretion levels and polysomnographic sleep parameters in healthy subjects and patients with sleep-related disturbances.

Richard Mahlberg1, Dieter Kunz.   

Abstract

BACKGROUND: The hormone melatonin plays a key role in the proper functioning of the circadian timing system (CTS). Exogenous melatonin has been shown to be beneficial in cases of CTS dysfunction and sleep disturbances. The aim of our study was to relate 24-h melatonin excretion to objective sleep measures.
METHODS: A total of 67 individuals were included in the study: 29 healthy subjects (16 women, 13 men; mean age 62.4 y, range 24-86) and 38 outpatients with neuropsychiatric sleep-related disturbances (25 women, 13 men; mean age 46.5 y, range 21-69). Over two consecutive nights in the sleep laboratory, polysomnographic (PSG) recordings were made and urine samples were collected at predefined intervals.
RESULTS: Our data failed to show any age-controlled partial correlation between 6-sulphatoxymelatonin (aMT6s) parameters and PSG parameters in either of the two groups.
CONCLUSION: Measuring endogenous melatonin does not seem to be an adequate way to evaluate sleep quality. This could be due to the fact that the size of the pineal gland and the amount of melatonin produced vary 20-fold between individuals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581781     DOI: 10.1016/j.sleep.2006.11.001

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  4 in total

Review 1.  Has adult sleep duration declined over the last 50+ years?

Authors:  Shawn D Youngstedt; Eric E Goff; Alexandria M Reynolds; Daniel F Kripke; Michael R Irwin; Richard R Bootzin; Nidha Khan; Girardin Jean-Louis
Journal:  Sleep Med Rev       Date:  2015-08-28       Impact factor: 11.609

2.  Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.

Authors:  Alan G Wade; Ian Ford; Gordon Crawford; Alex McConnachie; Tali Nir; Moshe Laudon; Nava Zisapel
Journal:  BMC Med       Date:  2010-08-16       Impact factor: 8.775

3.  Melatonin Level Variations with Different Behavioural Risk Factors in Obese Female Patients.

Authors:  Ana Malazonia; Tamar Zerekidze; Elen Giorgadze; Natia Chkheidze; Ketevan Asatiani
Journal:  Open Access Maced J Med Sci       Date:  2017-08-12

4.  Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.

Authors:  Amandine Descamps; Colette Rousset; Mark J Millan; Mark Millan; Michael Spedding; Philippe Delagrange; Raymond Cespuglio
Journal:  Psychopharmacology (Berl)       Date:  2009-04-16       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.